Musculoskeletal
diseases/disorders (MSDs) are diseases of muscles and related ligaments, and
other connective tissues and bones. Some of the most common musculoskeletal
diseases are back pain, osteoarthritis, rheumatoid arthritis, osteoporosis,
septic arthritis, gout, myasthenia gravis, systemic lupus erythematosus (SLE),
and some others. Musculoskeletal diseases are the prime cause of short term
disability and chronic disability in this generation.
MSDs are mostly caused
because of the over-use of weak muscles, tendons, or ligaments. Vigorous
vocational activities can cause musculoskeletal pain. In addition, as the
population ages, the prevalence of conditions such as osteoarthritis,
rheumatoid arthritis, and degenerative disc diseases increase. Unattended MSDs
lead to chronic disruption of the day-to-day and vocational activities of the
patient.
In the modern medicine
system, the most common drugs used for the treatment of musculoskeletal
diseases are analgesics, anti-inflammatory drugs, antipyretics,
immunosuppressives, muscle relaxants and corticosteroids. Though these drugs
show fair symptomatic relief, they have a number of side effects on the overall
well-being of the patient. Some of the most common side effects of MSD drugs
are nausea, acid-peptic disorders, liver and kidney damage, and irritation of
the gastric tract.
The burden of musculoskeletal diseases in every country is
considerably high. In the U.S. alone, one out of every four Americans suffers
from some kind of MSD. These disorders are one of the leading causes of
disability across the world.
The major therapeutics
used in the treatment of MSDs are biologics, corticosteroids, parathyroid
hormone, protein therapy, selective estrogen receptor modulators, synthetic
bone graft, composite grafts, demineralized bone matrix, BMPS, orthobiologics
and others. The global market for musculoskeletal diseases therapeutics will
witness large scale patent expiry which include some of the present top selling
drugs such as Celebrex and Cymbalta. Though large scale efforts in development
and commercialization of pipeline drugs is taking place, it is, however, viewed
that these products will not be able to cope with the challenges posed by
generic competition.
This research report
analyzes this market depending on its market segments, major geographies, and
current market trends. Geographies analyzed under this research report
include
North America
Asia Pacific
Europe
Rest of the World
This report
provides comprehensive analysis of
Market growth drivers
Factors limiting market growth
Current market trends
Market structure
Market projections for upcoming years
This report is a complete
study of current trends in the market, industry growth drivers, and restraints.
It provides market projections for the coming years. It includes analysis of
recent developments in technology, Porter’s five force model analysis and
detailed profiles of top industry players. The report also includes a review of
micro and macro factors essential for the existing market players and new
entrants along with detailed value chain analysis.
Browse All Market Research Report : http://www.transparencymarketresearch.com/
Posts
0 comments:
Post a Comment
Note: only a member of this blog may post a comment.